Logo image of AMTM

AMENTUM HOLDINGS INC (AMTM) Stock Fundamental Analysis

NYSE:AMTM - New York Stock Exchange, Inc. - US0239391016 - Common Stock - Currency: USD

20  -0.75 (-3.61%)

After market: 20 0 (0%)

Fundamental Rating

2

AMTM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 81 industry peers in the Professional Services industry. Both the profitability and financial health of AMTM have multiple concerns. AMTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

AMTM had negative earnings in the past year.
In the past year AMTM had a positive cash flow from operations.
AMTM Yearly Net Income VS EBIT VS OCF VS FCFAMTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

The Return On Assets of AMTM (-0.24%) is worse than 64.56% of its industry peers.
AMTM's Return On Equity of -0.64% is on the low side compared to the rest of the industry. AMTM is outperformed by 64.56% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.05%, AMTM is doing worse than 64.56% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AMTM is significantly below the industry average of 13.71%.
Industry RankSector Rank
ROA -0.24%
ROE -0.64%
ROIC 2.05%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
AMTM Yearly ROA, ROE, ROICAMTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

AMTM has a worse Operating Margin (2.62%) than 60.76% of its industry peers.
AMTM's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 9.82%, AMTM is not doing good in the industry: 91.14% of the companies in the same industry are doing better.
AMTM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.62%
PM (TTM) N/A
GM 9.82%
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
AMTM Yearly Profit, Operating, Gross MarginsAMTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10

2

2. Health

2.1 Basic Checks

AMTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AMTM remains at a similar level compared to 1 year ago.
Compared to 1 year ago, AMTM has an improved debt to assets ratio.
AMTM Yearly Shares OutstandingAMTM Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M
AMTM Yearly Total Debt VS Total AssetsAMTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

AMTM has an Altman-Z score of 1.34. This is a bad value and indicates that AMTM is not financially healthy and even has some risk of bankruptcy.
AMTM's Altman-Z score of 1.34 is on the low side compared to the rest of the industry. AMTM is outperformed by 70.89% of its industry peers.
The Debt to FCF ratio of AMTM is 20.96, which is on the high side as it means it would take AMTM, 20.96 years of fcf income to pay off all of its debts.
AMTM's Debt to FCF ratio of 20.96 is on the low side compared to the rest of the industry. AMTM is outperformed by 69.62% of its industry peers.
A Debt/Equity ratio of 1.04 is on the high side and indicates that AMTM has dependencies on debt financing.
AMTM has a worse Debt to Equity ratio (1.04) than 75.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 20.96
Altman-Z 1.34
ROIC/WACC0.21
WACC9.67%
AMTM Yearly LT Debt VS Equity VS FCFAMTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

AMTM has a Current Ratio of 1.59. This is a normal value and indicates that AMTM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.59, AMTM is in line with its industry, outperforming 58.23% of the companies in the same industry.
A Quick Ratio of 1.59 indicates that AMTM should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.59, AMTM perfoms like the industry average, outperforming 59.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
AMTM Yearly Current Assets VS Current LiabilitesAMTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

AMTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.53%, which is quite impressive.
Looking at the last year, AMTM shows a small growth in Revenue. The Revenue has grown by 6.65% in the last year.
Measured over the past years, AMTM shows a quite strong growth in Revenue. The Revenue has been growing by 12.53% on average per year.
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.26%
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%72.28%

3.2 Future

AMTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 113.04% yearly.
The Revenue is expected to grow by 3.37% on average over the next years.
EPS Next Y305.77%
EPS Next 2Y113.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.4%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMTM Yearly Revenue VS EstimatesAMTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 5B 10B
AMTM Yearly EPS VS EstimatesAMTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

AMTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 8.31, the valuation of AMTM can be described as reasonable.
AMTM's Price/Forward Earnings ratio is rather cheap when compared to the industry. AMTM is cheaper than 88.61% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AMTM to the average of the S&P500 Index (22.70), we can say AMTM is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.31
AMTM Price Earnings VS Forward Price EarningsAMTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AMTM.
AMTM's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AMTM is cheaper than 60.76% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.79
EV/EBITDA 15.72
AMTM Per share dataAMTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AMTM's earnings are expected to grow with 113.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y113.04%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AMTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMENTUM HOLDINGS INC

NYSE:AMTM (2/21/2025, 8:04:00 PM)

After market: 20 0 (0%)

20

-0.75 (-3.61%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)N/A N/A
Inst Owners55.74%
Inst Owner Change-90.47%
Ins Owners0.55%
Ins Owner Change14.58%
Market Cap4.87B
Analysts80
Price Target28.05 (40.25%)
Short Float %6.02%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.3%
Min EPS beat(2)10.29%
Max EPS beat(2)84.31%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.24%
Min Revenue beat(2)0.09%
Max Revenue beat(2)2.38%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.84%
PT rev (3m)N/A
EPS NQ rev (1m)16.67%
EPS NQ rev (3m)N/A
EPS NY rev (1m)49.65%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-2.54%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.31
P/S 0.5
P/FCF 21.79
P/OCF 20.27
P/B 1.09
P/tB N/A
EV/EBITDA 15.72
EPS(TTM)-0.34
EYN/A
EPS(NY)2.41
Fwd EY12.04%
FCF(TTM)0.92
FCFY4.59%
OCF(TTM)0.99
OCFY4.93%
SpS40.37
BVpS18.39
TBVpS-14.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.24%
ROE -0.64%
ROCE 2.59%
ROIC 2.05%
ROICexc 2.16%
ROICexgc 15.24%
OM 2.62%
PM (TTM) N/A
GM 9.82%
FCFM 2.27%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
ROICexc(3y)2.45%
ROICexc(5y)N/A
ROICexgc(3y)14.93%
ROICexgc(5y)N/A
ROCE(3y)2.92%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
F-Score5
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 20.96
Debt/EBITDA 8.08
Cap/Depr 5.29%
Cap/Sales 0.17%
Interest Coverage 250
Cash Conversion 41.83%
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z 1.34
F-Score5
WACC9.67%
ROIC/WACC0.21
Cap/Depr(3y)5.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.26%
EPS Next Y305.77%
EPS Next 2Y113.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%72.28%
Revenue Next Year2.4%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.17%
EBIT growth 3Y11.69%
EBIT growth 5YN/A
EBIT Next Year106.14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-30.5%
FCF growth 3Y-45.82%
FCF growth 5YN/A
OCF growth 1Y-30.26%
OCF growth 3Y-42.49%
OCF growth 5YN/A